sever
acut
respiratori
syndrom
sar
first
emerg
infecti
diseas
ten
year
ago
manifest
sever
form
pneumonia
etiolog
agent
identifi
novel
coronaviru
known
sar
coronaviru
sarscov
within
short
span
time
decemb
juli
newli
emerg
viru
spread
quickli
infect
peopl
across
countri
overal
fatal
rate
approxim
sarscov
zoonot
viru
cross
speci
barrier
infect
human
small
anim
palm
civet
paguma
larvata
raccoon
dog
nyctereut
procynonoid
sold
liveanim
wet
market
guangdong
provinc
southern
china
believ
zoonot
sourc
viru
transmit
human
complet
sequenc
sarslik
coronavirus
slcov
genet
homolog
sarscov
identifi
horsesho
bat
genu
rhinolophu
china
howev
slcov
display
signific
differ
sequenc
receptorbind
domain
rbd
compar
sarscov
unabl
use
sarscov
receptor
human
angiotensinconvert
enzym
cellular
entri
render
unlik
immedi
progenitor
sarscov
recent
bat
slcov
capabl
use
human
receptor
cellular
entri
character
isol
chines
horsesho
bat
provid
strong
evid
bat
natur
reservoir
sarscov
sarscov
classifi
viru
genu
betacoronaviru
lineag
b
famili
coronavirida
order
nidoviral
envelop
positivesens
singlestrand
rna
viru
genom
size
approxim
kb
encod
nonstructur
protein
accessori
protein
structur
protein
name
spike
envelop
e
membran
nucleocapsid
n
protein
everi
surfac
spike
sarscov
compos
trimer
protein
amino
acid
length
protein
type
glycoprotein
class
fusion
protein
respons
viral
attach
entri
host
cell
therefor
princip
determin
host
rang
consist
function
subunit
ntermin
subunit
amino
acid
ctermin
subunit
amino
acid
subunit
contain
rbd
recogn
sarscov
receptor
allow
attach
viru
host
cell
subunit
contain
put
fusion
peptid
two
heptad
repeat
import
sarscov
fusion
target
host
cell
upon
associ
rbd
receptor
conform
chang
trigger
result
insert
fusion
peptid
target
cell
membran
follow
interact
domain
antiparallel
manner
form
stabl
sixhel
bundl
fusion
core
allow
viral
membran
target
cell
membran
come
close
proxim
facilit
membran
fusion
viral
entri
besid
role
viral
entri
protein
also
major
antigen
determin
elicit
humor
immun
respons
infect
human
therefor
import
target
develop
vaccin
therapeut
intervent
sar
numer
human
murin
monoclon
antibodi
mab
bind
region
protein
identifi
shown
confer
neutral
activ
vitro
protect
vivo
sarscov
infect
subunit
protein
especi
rbd
highli
variabl
among
coronavirus
result
wide
rang
tissu
tropism
subunit
wellconserv
domain
indic
highli
conserv
natur
fusion
process
result
mab
broadli
neutral
characterist
wider
rang
sarscov
variant
includ
human
zoonot
sarscov
strain
recognit
highlyconserv
epitop
previou
studi
shown
panel
murin
mab
target
domain
region
upstream
protein
capabl
neutral
sarscov
infect
vitro
studi
crossneutr
abil
one
mab
term
investig
studi
abil
prevent
viral
entri
mediat
protein
sarscov
strain
civet
well
slcov
strain
bat
mab
bind
loop
region
domain
region
highli
conserv
known
function
figur
addit
escap
mutant
mab
gener
identifi
critic
residu
import
mab
bind
protein
found
mab
broad
crossneutr
activ
identifi
singl
amino
acid
aspart
acid
posit
crucial
interact
mab
use
pseudotyp
viral
entri
assay
shown
substitut
residu
alanin
mediat
escap
mab
neutral
addit
mutat
exert
effect
express
cell
surfac
incorpor
virion
particl
suggest
escap
viru
retain
viral
entri
properti
wildtyp
viru
ascit
produc
inject
hybridoma
cell
periton
caviti
pristineprim
balbc
mice
protocol
approv
institut
anim
care
use
committe
iacuc
biolog
resourc
centr
star
singapor
protocol
number
procedur
carri
strict
accord
recommend
nation
advisori
committe
laboratori
anim
research
naclar
guidelin
singapor
effort
made
minim
suffer
euthanasia
perform
use
carbon
dioxid
vero
american
type
cultur
collect
ft
cell
invitrogen
grown
dulbecco
modifi
eagl
medium
invitrogen
supplement
fetal
bovin
serum
hyclon
nonessenti
amino
acid
gibco
penicillin
unitsml
streptomycin
mgml
solut
sigma
aldrich
cho
cell
line
stabli
express
human
known
establish
previous
cultur
medium
cell
line
maintain
human
sarscov
strain
use
studi
antibodi
purifi
ascit
use
affin
chromatographi
briefli
ml
hitrap
protein
g
hp
bead
column
ge
healthcar
prewash
use
ml
mm
sodium
phosphat
buffer
ph
constant
flowrat
mlmin
use
peristalt
pump
ml
ascit
fluid
mix
equal
volum
mm
sodium
phosphat
buffer
pass
filter
filter
ascit
fluid
pass
column
flowrat
mlmin
extens
wash
perform
use
mm
sodium
phosphat
buffer
elut
buffer
glycinehcl
ph
pass
column
flowrat
mlmin
flowthrough
collect
ml
fraction
ml
microtub
contain
neutral
buffer
trishcl
ph
concentr
purifi
monoclon
antibodi
tube
determin
use
coomassi
plu
protein
assay
reagent
thermo
scientif
gener
escap
mutant
perform
biosafeti
level
laboratori
use
sarscov
strain
infect
vero
cell
presenc
differ
concentr
mab
concentr
mab
reduc
viru
titer
logarithm
log
determin
mgml
use
gener
viru
escap
mutant
serial
dilut
sarscov
rang
incub
presenc
mgml
mab
h
virusmab
mixtur
incub
vero
cell
plate
hour
virusmab
mixtur
remov
cell
wash
twice
medium
cell
incub
day
presenc
mab
concentr
mgml
supernat
well
contain
cell
exhibit
cytopath
effect
cpe
highest
dilut
sarscov
harvest
percentag
cpe
determin
visual
count
float
cell
attach
cell
well
float
cell
consid
cpe
supernat
incub
presenc
mgml
mab
h
virusmab
mixtur
use
infect
vero
cell
presenc
mab
concentr
mgml
perform
time
final
viru
sampl
ad
vero
cell
plate
incub
hour
well
overlaid
agaros
contain
mgml
mab
incub
day
five
plaqu
pick
use
pasteur
pipett
freezethaw
amplifi
vero
cell
neutral
test
perform
viru
clone
confirm
could
escap
neutral
mab
viral
rna
escap
viru
clone
isol
use
qiaamp
viral
rna
mini
kit
qiagen
convert
cdna
standard
revers
transcript
superscript
ii
revers
transcriptas
invitrogen
cdna
amplifi
pcr
use
specif
primer
target
gene
gener
long
fragment
amino
acid
short
fragment
amino
acid
gene
fragment
clone
vector
invitrogen
five
coloni
sequenc
gene
human
sarscov
strain
obtain
viral
rna
revers
transcript
pcr
clone
express
vector
use
bamhi
xhoi
restrict
site
chimer
gene
civet
sarscov
strain
bat
slcov
strain
design
replac
receptorbind
domain
rbd
human
sarscov
strain
arginin
r
residu
posit
substitut
lysin
k
serin
residu
posit
substitut
phenylalanin
f
lysin
posit
substitut
asparagin
serin
posit
substitut
threonin
rbd
domain
amino
acid
replac
rbd
domain
amino
acid
human
chemic
synthes
genscript
usa
inc
piscataway
nj
clone
express
vector
use
restrict
site
gener
plasmid
express
mutant
specif
primer
design
tworound
pcr
sitedirect
mutagenesi
wildtyp
gene
use
expand
high
fidel
pcr
system
roch
pcr
product
clone
express
vector
use
bamhi
xhoi
restrict
site
form
plasmid
express
plasmid
express
wildtyp
mutant
human
sarscov
chimer
civet
sarscov
bat
slcov
gene
transient
transfect
ft
cell
use
lipofectamin
reagent
invitrogen
accord
manufactur
protocol
cell
harvest
hour
posttransfect
scrap
cell
spun
centrifug
wash
cold
pb
twice
cell
resuspend
lysi
buffer
mm
tri
ph
mm
nacl
deoxychol
acid
sd
mm
phenylmethylsulfonyl
fluorid
subject
freezethaw
five
time
follow
spin
rpm
remov
cell
debri
cell
lysat
protein
concentr
quantit
use
commassi
plu
protein
assay
reagent
thermo
scientif
use
western
blot
analysi
immunoprecipit
ip
western
blot
analysi
protein
separ
polyacrylamid
gel
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
sdspage
transfer
onto
nitrocellulos
membran
membran
block
skim
milk
trisbuff
salin
tb
tween
tbst
incub
primari
antibodi
mab
overnight
membran
wash
tbst
incub
goat
antimous
horseradish
peroxidas
hrp
conjug
antibodi
pierc
secondari
antibodi
room
temperatur
hour
membran
wash
tbst
follow
addit
enhanc
chemiluminesc
substrat
pierc
film
develop
ip
mab
use
pull
wildtyp
mutant
protein
cell
lysat
hour
follow
addit
protein
bead
roch
incub
overnight
bead
wash
lysi
buffer
three
time
subject
western
blot
analysi
detect
protein
use
rabbit
antibodi
bind
amino
acid
subunit
primari
antibodi
goat
antirabbit
hrpconjug
antibodi
pierc
secondari
antibodi
fragment
aa
express
gst
glutathionetransferas
fusion
protein
use
vector
ge
healthcar
fragment
locat
subunit
amino
acid
contain
mab
bind
site
wildtyp
mutant
fragment
express
escherichia
coli
cultur
grown
terrif
broth
reach
optic
densiti
nm
nm
cell
cool
induc
isopropyl
iptg
final
concentr
mm
incub
period
hour
cell
harvest
bacteri
pellet
resuspend
lysi
buffer
contain
sarkosyl
subject
sonic
lysat
clear
centrifug
incub
gluthathion
gsh
sepharos
bead
ge
heathcar
overnight
sever
wash
gsttag
fragment
elut
bead
mm
reduc
gluthathion
solut
sigma
aldrich
purifi
fragment
subject
sdspage
gel
stain
use
coomassi
blue
visual
puriti
protein
purifi
wildtyp
mutant
gst
aa
protein
coat
onto
elisa
plate
nunc
overnight
ngwell
well
block
skim
milk
phosphatebuff
salin
pb
tween
pbst
hour
room
temperatur
primari
antibodi
mab
mous
antigst
antibodi
santa
cruz
ad
primari
antibodi
dilut
incub
hour
well
wash
pbst
follow
addit
goat
antimous
hrpconjug
antibodi
pierc
secondari
antibodi
incub
hour
tetramethylbenzidin
substrat
pierc
ad
reaction
stop
use
sulphur
acid
optic
densiti
nm
nm
obtain
use
absorb
reader
tecan
infinit
statist
differ
bind
mab
wildtyp
mutant
analys
use
unpair
ttest
signific
indic
pvalu
abil
sarscov
contain
mutant
infect
cell
result
effect
mab
neutral
sarscov
entri
studi
use
pseudotyp
viru
system
base
pseudotyp
viru
system
replic
incompet
lentivir
particl
express
protein
surfac
contain
firefli
luciferas
report
gene
use
replac
live
sarscov
viral
entri
permiss
cell
line
reflect
luciferas
activ
infect
cell
gener
spseudotyp
particl
spp
lentivir
vector
plasmid
express
gene
cotransfect
ft
cell
use
lipofectamin
reagent
invitrogen
accord
manufactur
protocol
hour
posttransfect
viral
supernat
collect
spun
centrifug
remov
cell
debri
elisa
quicktit
lentiviru
titer
kit
cell
biolab
use
accord
manufactur
protocol
quantifi
viral
titr
spp
neutral
assay
carri
plate
cell
grown
ul
grow
media
per
well
hour
experi
spp
neutral
assay
ng
spp
quantifi
use
elisa
preincub
mab
mab
hour
room
temperatur
mabviru
mixtur
viru
alon
use
infect
cell
incub
nonneutr
antibodi
bind
rbd
mab
use
control
antibodi
hour
postinfect
cell
harvest
use
luciferas
assay
system
promega
luciferas
express
cell
determin
accord
manufactur
protocol
percentag
viral
entri
calcul
base
luciferas
read
obtain
experi
carri
triplic
statist
differ
viral
entri
wildtyp
mutant
spp
done
use
unpair
ttest
signific
indic
pvalu
spp
coat
onto
elisa
plate
nunc
ngwell
quantit
elisa
overnight
well
block
skim
milk
pb
tween
pbst
primari
antibodi
mab
mous
antibodi
ad
primari
antibodi
dilut
incub
hour
well
wash
pbst
follow
addit
goat
antimous
hrpconjug
antibodi
pierc
secondari
antibodi
incub
hour
tetramethylbenzidin
substrat
pierc
ad
reaction
stop
use
sulphur
acid
nm
obtain
use
absorb
reader
tecan
infinit
differ
protein
level
wildtyp
mutant
spp
evalu
use
unpair
ttest
ft
cell
seed
dish
hour
prior
transfect
cell
transfect
empti
vector
plasmid
use
lipofectamin
reagent
invitrogen
accord
manufactur
protocol
harvest
hour
posttransfect
cell
first
detach
use
cell
dissoci
solut
sigma
wash
twice
pb
incub
purifi
mous
mab
bind
subunit
pb
contain
bovin
serum
albumin
bsa
hour
nutat
cell
wash
time
use
pb
contain
bsa
incub
fluorescein
isothiocyan
fitc
conjug
goat
antimous
igg
santa
cruz
secondari
antibodi
hour
nutat
cell
wash
time
immedi
use
fac
analysi
use
cyan
flow
cytomet
beckman
coulter
fac
data
analys
use
flowjo
softwar
applic
describ
previou
public
panel
neutral
mab
larg
group
type
ii
iii
iv
base
bind
site
protein
membran
fusion
experi
found
mab
belong
type
ii
effect
cellcel
membran
block
bound
residu
immedi
upstream
domain
figur
contribut
mab
bind
site
structur
function
defin
chose
mab
investig
studi
order
gain
better
understand
neutral
mechan
mab
sequenc
align
show
residu
highli
conserv
region
within
subunit
human
civet
sarscov
bat
slcov
strain
figur
demonstr
ren
et
al
bat
slcov
use
differ
unknown
receptor
entri
thu
could
infect
cell
express
human
receptor
order
evalu
viral
entri
properti
civet
sarscov
bat
slcov
strain
receptorbind
domain
rbd
civet
sarscov
strain
bat
slcov
strain
replac
rbd
human
sarscov
creat
chimer
protein
figur
allow
viral
attach
step
bind
rbd
human
receptor
western
blot
analysi
mab
found
abl
bind
subunit
civet
sarscov
bat
slcov
strain
similar
extent
homolog
human
sarscov
figur
antibodi
target
domain
human
sarscov
protein
mab
use
determin
rel
express
chimer
protein
figur
next
determin
mab
exhibit
crossneutr
activ
spseudotyp
viru
particl
spp
carri
human
sarscov
variou
rbdmodifi
chimer
civet
sarscov
strain
bat
slcov
strain
gener
use
infect
cell
absenc
presenc
differ
concentr
mab
pseudotyp
viru
system
replic
incompet
lentivir
particl
express
protein
surfac
use
replac
live
sarscov
slcov
system
success
employ
studi
highli
pathogen
virus
includ
influenza
viru
sarscov
neutral
antibodi
titer
measur
use
pseudotyp
sarscov
correl
well
use
replic
compet
sarscov
system
wide
use
evalu
sarscov
neutral
antibodi
studi
spp
express
human
sarscov
rbdmodifi
chimer
civet
sarscov
strain
bat
slcov
strain
abl
infect
enter
cell
similar
extent
figur
file
result
obtain
mab
neutral
assay
figur
figur
file
show
mab
apart
abl
neutral
spp
express
human
sarscov
abl
crossneutr
spp
express
chimer
civet
sarscov
bat
slcov
indic
mab
broad
neutral
capabl
identifi
critic
residu
requir
mab
interact
mab
escap
mutant
gener
sarscov
strain
cultur
vero
cell
suboptim
level
mab
mgml
supernat
well
contain
cell
exhibit
cytopath
effect
cpe
highest
dilut
sarscov
harvest
passag
passag
time
presenc
mab
mgml
viru
titr
gradual
increas
figur
plaqu
assay
done
isol
individu
sarscov
escap
mutant
clone
wildtyp
escap
mutant
virus
use
subject
neutral
assay
mab
mab
vero
cell
determin
cytopath
effect
cpe
escap
mutant
clone
resist
neutral
mab
result
one
repres
clone
shown
figur
percentag
cpe
vero
cell
infect
wildtyp
viru
decreas
significantli
mab
concentr
mgml
figur
contrast
cpe
still
observ
escap
mutant
virusinfect
cell
even
presenc
mgml
mab
figur
indic
mutant
viru
resist
neutral
mab
howev
wildtyp
mutant
viru
equal
sensit
neutral
anoth
mab
figur
bind
epitop
residu
differ
mab
confirm
escap
abil
escap
mutant
clone
viral
rna
extract
gene
sequenc
two
escap
mutat
identifi
mab
escap
mutant
clone
mutat
clone
mutat
none
clone
mutat
wildtyp
substitut
mutant
name
contain
express
ft
cell
western
blot
analysi
perform
determin
effect
mutat
bind
protein
mab
shown
figur
protein
contain
mutat
show
reduc
bind
mab
compar
wildtyp
protein
swt
protein
mutat
show
reduct
mab
bind
compar
swt
western
blot
reveal
bind
mab
denatur
epitop
immunoprecipit
ip
perform
compar
mab
bind
nativ
form
consist
result
obtain
western
blot
analysi
exhibit
decreas
mab
bind
compar
swt
figur
similar
result
also
observ
elisa
figur
file
use
wildtyp
mutant
gst
fragment
express
bacteria
cell
figur
file
result
suggest
residu
import
bind
mab
protein
addit
protein
contain
mutat
evalu
synergist
effect
reduct
mab
bind
western
blot
immunoprecipit
shown
figur
b
signific
synergist
effect
observ
mutat
identifi
escap
sarscov
mutant
clone
gener
mab
verifi
two
mutat
contribut
escap
neutral
mab
vitro
pseudotyp
viru
assay
spp
express
wildtyp
mutant
mutant
mutant
protein
gener
seen
figur
file
spp
abl
infect
enter
cell
mutant
spp
show
slightli
lower
infect
compar
wildtyp
use
infect
cell
absenc
presenc
differ
concentr
mab
neutral
activ
mab
wildtyp
spp
compar
mab
nonneutr
mab
use
control
antibodi
shown
figur
figur
file
highest
concentr
mab
prevent
viral
entri
wildtyp
spp
cell
respect
entri
significantli
affect
lower
concentr
mab
similar
result
obtain
suggest
resist
mab
neutral
indic
reduct
bind
mab
observ
western
blot
ip
elisa
mutat
protein
suffici
mediat
escap
neutral
mab
addit
spp
contain
mutat
investig
resist
mab
neutral
also
resist
mab
neutral
similar
extent
figur
figur
file
indic
synergist
effect
mutat
confer
mab
resist
viral
particl
resist
neutral
observ
spp
mab
anoth
neutral
mab
bind
differ
epitop
within
subunit
amino
acid
figur
figur
file
mutat
within
coronaviru
protein
profound
effect
synthesi
matur
process
protein
result
decreas
cell
surfac
express
well
defect
incorpor
matur
virion
particl
evalu
possibl
effect
mutat
matur
process
protein
synthesi
fac
analysi
perform
compar
cell
surfac
express
wildtyp
wt
mutant
protein
transfect
ft
cell
vectortransfect
wildtyp
stransfect
mutant
stransfect
cell
incub
mab
bind
subunit
follow
fitcconjug
antimous
secondari
antibodi
posit
shift
fluoresc
observ
wildtyp
sexpress
cell
compar
vectortransfect
cell
figur
specif
bind
mab
nativ
form
protein
express
cell
surfac
comparison
mutant
sexpress
cell
show
similar
degre
shift
fluoresc
express
wildtyp
figur
thu
mutat
reduc
surfac
level
express
protein
suggest
substitut
residu
hamper
synthesi
process
protein
determin
mutant
protein
incorpor
spp
effici
wildtyp
equal
amount
wildtyp
spp
coat
onto
elisa
plate
mab
use
compar
amount
protein
spp
observ
signific
differ
express
wildtyp
mutant
protein
spp
figur
top
indic
mutat
caus
chang
effici
protein
incorpor
viral
particl
mab
use
instead
mab
nm
read
obtain
similar
confirm
equal
amount
spp
virus
success
coat
elisa
plate
figur
bottom
although
report
case
sarscov
infect
human
sinc
develop
antisarscov
treatment
vaccin
remain
crucial
threat
reemerg
sar
exist
till
today
human
civet
sarscov
believ
origin
slcov
resid
bat
coronavirus
known
capabl
frequent
crossspeci
transmiss
continu
persist
slcov
anim
host
reservoir
pose
threat
human
crossspeci
transmiss
occur
develop
broadli
neutral
mab
confer
crossprotect
human
sarscov
also
zoonot
strain
sarscov
slcov
therefor
import
put
subunit
bat
slcov
low
sequenc
homolog
sarscov
especi
rbd
indic
usag
differ
host
cell
receptor
differ
tissu
tropism
hand
high
sequenc
homolog
subunit
suggest
fusion
mechan
viral
infect
wellconserv
broadli
neutral
mab
usual
target
conserv
epitop
requir
highli
conserv
process
postattach
fusion
process
major
sarscovneutr
mab
report
bind
target
protein
rbd
region
nonetheless
neutral
mab
bind
subunit
report
epitop
mab
found
locat
subunit
upstream
residu
within
loop
region
residu
within
domain
residu
also
shown
mab
bind
highli
conserv
ectodomain
sarscov
protein
abl
neutral
wider
rang
clinic
isol
includ
human
zoonot
strain
sarscov
current
studi
mab
mab
bind
subunit
highli
conserv
loop
region
residu
demonstr
abl
crossneutr
pseudotyp
spp
virus
human
sarscov
civet
sarscov
bat
slcov
strain
consist
sequenc
conserv
mab
bind
epitop
addit
sequenc
align
shown
reveal
mab
bind
site
also
conserv
bat
cov
bulgarian
sarsrel
cov
strain
indic
potenti
crossprotect
effect
mab
bat
slcov
china
also
part
world
europ
sever
crossneutr
mab
human
civet
sarscov
strain
target
rbd
describ
valu
rang
observ
studi
valu
mab
higher
rbdtarget
mab
indic
lower
potenc
mab
higher
valu
lower
potenc
also
observ
sever
mab
possibl
attribut
inaccess
subunit
constitut
stalk
region
compar
subunit
expos
viral
surfac
howev
sarscov
capabl
attain
mutat
rbd
region
without
affect
viral
infect
lead
escap
mab
neutral
mutat
within
highli
conserv
subunit
region
like
detriment
mutant
viru
therefor
character
mab
remain
import
develop
antibodi
antivir
therapi
sarscov
gener
mab
escap
viru
found
escap
mutat
protein
result
diminish
bind
mab
pseudotyp
viral
particl
contain
mutat
could
neutral
mab
addit
substitut
either
n
sidechain
e
charg
also
reduc
interact
mab
similar
extent
substitut
figur
file
thu
appear
residu
posit
protein
play
essenti
role
interact
mab
anoth
mutat
also
identifi
mab
escap
viru
found
effect
mab
bind
neutral
indic
like
random
mutat
aros
gener
escap
mutant
signific
synergist
effect
observ
mutat
decreas
mab
bind
confer
resist
mab
neutral
inform
possibl
function
role
mab
bind
epitop
residu
cell
surfac
express
mutant
incorpor
virallik
particl
compar
wildtyp
result
show
similar
wildtyp
aspect
suggest
viral
entri
properti
escap
viru
chang
summari
character
mab
sarscov
neutral
mab
bind
novel
epitop
locat
within
loop
region
locat
posit
directli
upstream
residu
protein
previous
identifi
character
aspart
acid
residu
crucial
interact
protein
mab
substitut
alanin
escap
viru
suffici
abolish
neutral
mab
littl
effect
viral
entri
properti
consist
detail
studi
fit
escap
viru
perform
observ
viru
titr
escap
viru
passag
presenc
mab
reach
similar
level
wildtyp
viru
see
figur
howev
rule
possibl
mutat
may
affect
viral
virul
work
need
address
loop
region
subunit
believ
region
requir
viralcel
membran
fusion
peptid
analog
loop
region
found
inhibit
sarscov
infect
although
residu
shown
directli
involv
membran
fusion
probabl
bind
mab
residu
loop
region
caus
steric
hindranc
prevent
associ
form
sixhel
fusion
bundl
core
henc
structur
analysi
interact
mab
activ
pursu
order
defin
inhibit
mechan
mab
